63
|
162
|
7l3jA |
T4 lysozyme l99a - benzylacetate - rt |
64
|
164
|
7l3gA |
T4 lysozyme l99a - 4-iodotoluene - cryo |
63
|
162
|
7l3dA |
T4 lysozyme l99a - 3-iodotoluene - rt |
67
|
162
|
7l3cA |
T4 lysozyme l99a - o-xylene - rt |
62
|
162
|
7l37A |
T4 lysozyme l99a - apo - rt |
64
|
162
|
7l3kA |
T4 lysozyme l99a - benzylacetate - cryo |
65
|
162
|
7l3fA |
T4 lysozyme l99a - 4-iodotoluene - rt |
62
|
162
|
7l38A |
T4 lysozyme l99a - apo - cryo |
63
|
162
|
7l3aA |
T4 lysozyme l99a - toluene - cryo |
64
|
162
|
7l3iA |
T4 lysozyme l99a - propylbenzene - rt |
62
|
162
|
7l3hA |
T4 lysozyme l99a - ethylbenzene - rt |
66
|
162
|
7l3bA |
T4 lysozyme l99a - iodobenzene - rt |
62
|
162
|
7l3eA |
T4 lysozyme l99a - 3-iodotoluene - cryo |
62
|
162
|
7l39A |
T4 lysozyme l99a - toluene - rt |
60
|
162
|
7lx6A |
T4 lysozyme mutant l99a |
56
|
161
|
7lxaA |
T4 lysozyme mutant l99a |
58
|
161
|
7logA |
T4 lysozyme mutant l99a in complex with 3-butylpyridine |
175
|
438
|
7f8yA |
Crystal structure of the cholecystokinin receptor cckar in complex with devazepide |
173
|
438
|
7f8uA |
Crystal structure of the cholecystokinin receptor cckar in complex with lintitript |
170
|
446
|
6zfzA |
Structure of m1-star-t4l in complex with 77-lh-28-1 at 2.17a |
183
|
446
|
6zg4A |
Structure of m1-star-t4l in complex with htl0009936 at 2.35a |
166
|
446
|
6zg9A |
Structure of m1-star-t4l in complex with gsk1034702 at 2.5a |
83
|
329
|
6wskA |
Crystal structure of the cannabinoid receptor 1 interacting protein 1a (crip1a) |
137
|
372
|
7kwaA |
Structure of dcn1 bound to n-((4s,5s)-3-(aminomethyl)-7-ethyl-4-(4-fluorophenyl)-6-oxo-1-phenyl-4,5,6,7-tetrahydro-1h-pyrazolo[3,4-b]pyridin-5-yl)-3-(trifluoromethyl)benzamide |
76
|
257
|
6zx9C |
Crystal structure of siv vpr,fused to t4 lysozyme, isolated from moustached monkey, bound to human ddb1 and human dcaf1 (amino acid residues 1046-1396) |
43
|
164
|
7dwsA |
The structure of t4 lysozyme i3c/c54t/r125c/e128c complex with zinc ions |
129
|
361
|
6xolA |
Dcn1 bound to di-1548 |
126
|
353
|
6xonA |
Dcn1 bound to inhibitor 9 |
128
|
361
|
6xoqA |
Dcn1 covalently bound to inhibitor 4 |
126
|
361
|
6xopA |
Dcn1 bound to inhibitor 10 |
130
|
361
|
6xooA |
Dcn1 bound to di-1859 |
126
|
361
|
6xomA |
Dcn1 bound to 8 |
382
|
1412
|
7mi3A |
Signal subtracted reconstruction of aaa2, aaa3, and aaa4 domains of dynein in the presence of a pyrazolo-pyrimidinone-based compound, model 4 |
259
|
2488
|
7mi8A |
Signal subtracted reconstruction of aaa5 and aaa6 domains of dynein in the presence of a pyrazolo-pyrimidinone-based compound, model 5 |
60
|
162
|
7lx7A |
T4 lysozyme mutant l99a |
61
|
163
|
7locA |
T4 lysozyme mutant l99a in complex with 1-bromanyl-4-fluoranyl-benzene |
62
|
162
|
7lobA |
T4 lysozyme mutant l99a in complex with 1-fluoro-2-[(prop-2-en-1-yl)oxy]benzene |
63
|
162
|
7lodA |
T4 lysozyme mutant l99a in complex with 1-fluoranyl-4-iodanyl-benzene |
58
|
162
|
7lojA |
T4 lysozyme mutant l99a in complex with 4-(3-phenylpropyl)aniline |
59
|
162
|
7lx9A |
T4 lysozyme mutant l99a |
61
|
163
|
7loaA |
T4 lysozyme mutant l99a in complex with 3-fluoroiodobenzene |
59
|
162
|
7lx8A |
T4 lysozyme mutant l99a |
59
|
163
|
7loeA |
T4 lysozyme mutant l99a in complex with 1-fluoranylnaphthalene |
59
|
163
|
7lofA |
T4 lysozyme mutant l99a in complex with 2-butylthiophene |
57
|
164
|
6u0eA |
Neutron crystal structure of t4l m6ae |
333
|
934
|
7c2nA |
Crystal structure of mycolic acid transporter mmpl3 from mycobacterium smegmatis complexed with spiro |
332
|
934
|
7c2mA |
Crystal structure of mycolic acid transporter mmpl3 from mycobacterium smegmatis complexed with nitd-349 |
133
|
357
|
6xyrA |
Structure of the t4lnano fusion protein |
186
|
455
|
7btsA |
Structure of human beta1 adrenergic receptor bound to epinephrine and nanobody 6b9 |
180
|
509
|
7bu7A |
Structure of human beta1 adrenergic receptor bound to bi-167107 and nanobody 6b9 |